Benzannulated spiroketal natural products exhibit a broad array of biological activities.^[@ref1]^ Examples include the matrix metalloproteinase inhibitor berkelic acid,^[@ref2]^ the fungal cell wall glucan synthase inhibitory papulacandins,^[@ref3]^ and the anti-inflammatory aquilarinoside A.^[@ref4]^ Bisbenzannulated spiroketals include the rubromycin family of human telomerase and HIV reverse transcriptase inhibitors,^[@ref5]^ the DNA helicase inhibitor heliquinomycin, and the antibiotic purpuromycin, which inhibits aminoacyl-tRNA synthesis by a novel mechanism involving direct binding to the tRNA substrate.^[@ref6]^ Notably, the benzannulated spiroketal core is essential for telomerase inhibition in the rubromycin family.^[@ref7]^ Numerous approaches to the synthesis of benzannulated spiroketals have been reported.^[@ref8],[@ref9]^ Despite these notable advances, most strategies rely upon thermodynamically controlled reactions that often lead to stereoisomeric mixtures at the anomeric carbon.^[@ref1]^

We have previously developed stereocontrolled approaches to aliphatic spiroketals using stereocomplementary kinetic spirocyclization reactions of *endo*-glycal epoxides that proceed with either inversion or retention of configuration at the anomeric carbon, independent of thermodynamic preferences.^[@ref10]^ We have also extended this approach to benzannulated spiroketals via incorporation of aromatic rings on the cyclizing side chain.^[@ref11]^ Unfortunately, this approach provides low diastereoselectivity in spirocyclization reactions with phenolic nucleophiles (45:55 to 58:42 dr).^[@ref11]^

To address this problem, we envisioned an alternative entry to phenolic spiroketals involving stereoselective spirocyclizations of benzannulated *exo*-glycal epoxides (dihydrobenzofuran spiroepoxides). Spirocyclizations of exocyclic enol ether epoxides have apparently not been explored previously, although classical acid-catalyzed spiroketalizations of the parent exocyclic enol ethers are well-known,^[@ref12]^ and the corresponding epoxides^[@ref13]^ have been used in intermolecular alcohol additions.^[@ref14]^

Thus, the requisite benzannulated *exo*-glycal epoxide substrates were synthesized from salicylaldehydes **1** via alkyne additions to form propargyl alcohols **2a**--**h** (Figure [1](#fig1){ref-type="fig"}).^[@ref15]^ Au(I)-mediated cycloisomerization, previously restricted to aromatic alkynes,^[@ref15],[@ref16]^ then afforded *exo*-glycals **5a**--**h**. Diastereoselective *anti*-epoxidation with dimethyldioxirane (DMDO)^[@ref17]^ provided *exo*-glycal epoxides **6a**--**h**. Interestingly, these epoxides were stable upon warming to rt, in stark contrast to the corresponding *endo*-glycal epoxides, which cyclize spontaneously at −35 °C.^[@ref18]^

![Synthesis of *exo*-glycal epoxide substrates **6a**--**h**.](ol-2014-00853q_0002){#fig1}

We next explored spirocyclization reactions of benzannulated *exo*-glycal epoxide **6a** (Table [1](#tbl1){ref-type="other"}). Notably, **6a** proved unreactive under our previously reported MeOH and Ti(O-*i*-Pr)~4~ spirocyclization conditions, as well as upon heating to 120 °C in toluene (entries 1--3). After investigating a wide range of Lewis acids,^[@ref16]^ we were encouraged to find that Sc(OTf)~3~ favored the inversion product **7a** (entry 4), which could be formed exclusively by changing the reaction solvent from CH~2~Cl~2~ to THF (entry 5). The diastereoselectivity decreased slightly with substoichiometric Sc(OTf)~3~ (entries 6 and 7). Other Lewis acids gave lower or even reversed diastereoselectivity.^[@ref16]^

###### Spirocyclization Reactions of *exo*-Glycal Epoxide **6a**[a](#t1fn1){ref-type="table-fn"}

![](ol-2014-00853q_0004){#fx1}

  entry    reagent (equiv)                  solvent, temp (°C)                       **7a**:**8a**
  -------- -------------------------------- ---------------------------------------- ---------------
  1        MeOH (excess)                    MeOH, rt                                 NR
  2        Ti(O^i^Pr)~4~ (2.0)              CH~2~Cl~2~, rt                           NR
  3                                         toluene, 120                             NR
  4        Sc(OTf)~3~ (2.0)                 CH~2~Cl~2~, −78 → 0                      75:25
  5        Sc(OTf)~3~ (2.0)                 THF, −78 → 0                             \>98:2
  6        Sc(OTf)~3~ (1.0)                 THF, −78 → 0                             \>98:2
  7        Sc(OTf)~3~ (0.1)                 THF, −78 → 0                             93:7
  **8**    **Sc(OTf)**~**3**~**(1.0)**      **THF, −20**                             **\>98:2**
  9        Sc(OTf)~3~ (1.0)                 THF, rt                                  90:10
  10       Sc(OTf)~3~ (1.0)                 CH~2~Cl~2~, 0 → rt                       \<2:98
  **11**   **Sc(OTf)**~**3**~**(0.5)**      **CH**~**2**~**Cl**~**2**~, **0 → rt**   **\<2:98**
  12       Sc(OTf)~3~ + DTBMP (1.0 + 1.0)   THF, −20                                 \>98:2
  13       ScCl~3~ (1.0)                    THF, rt                                  \>98:2
  14       TfOH (1.0)                       THF, −20                                 30:70
  15       Sc(OTf)~3~ + DTBMP (0.5 + 0.5)   CH~2~Cl~2~, 0 → rt                       75:25
  16       TfOH (0.5)                       CH~2~Cl~2~, 0 → rt                       \<2:98
  17       TfOH + DTBMP (0.5 + 0.5)         CH~2~Cl~2~, 0 → rt                       51:49

Product ratios determined by ^1^H NMR analysis of crude reaction products. NR = no reaction; DTBMP = 2,6-di-*tert*-butyl-4-methylpyridine. See the [Supporting Information](#notes-1){ref-type="notes"} for the complete table.

In low-temperature ^1^H NMR experiments, we found that the Sc(OTf)~3~-mediated spirocyclization begins to occur at −35 °C.^[@ref16]^ Complete selectivity for spirocyclization with inversion of configuration was maintained when the reaction was run at −20 °C (entry 8), but selectivity decreased at higher temperatures (entry 9), suggesting that the reaction proceeds under kinetic control between −35 and −20 °C.

Strikingly, when the room-temperature reaction was carried out in CH~2~Cl~2~ instead of THF, thermodynamic equilibration of an initially formed diastereomeric mixture afforded the retention product **8a** with complete stereoselectivity (entries 10, 11).^[@ref19]^ A structural rationale for the observed thermodynamic preference is nonobvious, due to the conformational flexibility of 5-membered rings,^[@ref20]^ and remains a subject for further investigation. However, on the basis of these results, it is apparent that Sc(OTf)~3~ plays divergent roles in the spirocyclization reactions depending upon solvent selection (THF vs CH~2~Cl~2~, entry 9 vs 10).

It is known that metal triflates can serve as a mild source of triflic acid.^[@ref21]^ Thus, we carried out mechanistic studies to differentiate between the Lewis and Brønsted acid activities of Sc(OTf)~3~. Inclusion of the noncoordinating Brønsted base, 2,6-di-*tert*-butyl-4-methylpyridine (DTBMP),^[@cit21a]^ in the reaction in THF did not affect diastereoselectivity (entry 8 vs 12). Treatment with ScCl~3~ at rt also led to complete stereoselectivity for the contrathermodynamic spiroketal **7a** (entry 13). In contrast, spirocyclization with TfOH afforded a diastereomeric mixture favoring the retention product **8a** (entry 14). Taken together, these results suggest that Sc(OTf)~3~ acts as a Lewis acid in THF at reduced temperatures, catalyzing formation of the contrathermodynamic spiroketal **7a** under kinetic control.

We next carried out the analogous experiments in CH~2~Cl~2~ where, upon warming to rt, Sc(OTf)~3~ favors the retention product **8a** (entry 11). In contrast, inclusion of DTBMP resulted in a diastereomeric mixture favoring the inversion product **7a** (entry 15). However, spirocyclization with TfOH provided the retention product **8a** exclusively (entry 16). Treatment with both TfOH and DTBMP afforded a diastereomeric mixture of spiroketals, similar to the result observed with Sc(OTf)~3~ and DTBMP (entry 17 vs 15). Collectively, these results suggest that Sc(OTf)~3~ acts as a mild source of Brønsted acid in CH~2~Cl~2~ at rt, catalyzing formation of the thermodynamically favored spiroketal **8a** under equilibrium control.

We then investigated the scope of these stereocomplementary Sc(OTf)~3~-catalyzed spirocyclization reactions. Substrates with longer side chains (**6b**, **6c**) and various aryl substituents (**6d**--**h**) were synthesized from the corresponding alkyne and salicylaldehyde precursors (Figure [1](#fig1){ref-type="fig"}). The bromide intermediate **4h** was also used to introduce other substituents (aryl, alkyne, azide, aldehyde, ester, imide) in **4i**--**n** to examine the functional group tolerance of the spirocyclization reactions (Figure S2, [Supporting Information](#notes-1){ref-type="notes"}).^[@ref16]^ The *exo*-glycals **4i**--**n** were then converted to the corresponding epoxide substrates **6i**--**n** (Figure S2, [Supporting Information](#notes-1){ref-type="notes"}).^[@ref16]^

In the spirocyclization reactions, both diastereomers of the larger 6- and 7-membered ring spiroketals (**7b**,**c** and **8b**,**c**) could be obtained with complete diastereoselectivity based on solvent selection (Figure [2](#fig2){ref-type="fig"}). For **8b**, equilibration with Sc(OTf)~3~ in CH~2~Cl~2~ required elevated temperature (60 °C). The 7-membered ring spiroketal **7c** was obtained in somewhat lower yield due to an unexpected anti-Markovnikov 6-*exo* epoxide opening side reaction leading to a benzofuran product.^[@ref16]^

![Scope of Sc(OTf)~3~-mediated spirocyclization reactions. (a) THF: 1.0 equiv Sc(OTf)~3~, THF, −20 °C, 2--3 h; CH~2~Cl~2~: 0.5 equiv Sc(OTf)~3~, CH~2~Cl~2~, 0 °C to rt, 1--12 h; diastereomeric ratios determined by ^1^H NMR analysis of crude reaction mixtures; stereochemistry assigned based on NOESY analysis except **8b**, which was determined by X-ray crystallography;^[@ref16]^ isolated yields after column chromatography shown in parentheses. (b) 60 °C. (c) 30% anti-Markovnikov 6-*exo*-cyclization side product also recovered.^[@ref16]^ (d) rt.](ol-2014-00853q_0003){#fig2}

Next, we investigated the electronic effects of various aryl substituents. A wide range of electron-withdrawing and -donating groups were tolerated (**7d**--**n**, **8d**--**n**), and high diastereoselectivities were maintained. Notably, the nitro-substituted substrate **6d** was less reactive and required more forcing conditions (**7d**: rt; **8d**: 6 h). Conversely, the methoxy-substituted substrate **6e** was highly reactive, providing slightly decreased diastereoselectivity in the THF reaction (**7e**: 93:7 dr) and rapid equilibration in the CH~2~Cl~2~ reaction (**8e**: 1 h). These results are consistent with the expected electronic influence of these *para* substituents upon the reactive anomeric spiroepoxide center.^[@ref18]^

The reactions also tolerated other reactive functionalities including alkyne (**7j**, **8j**), azide (**7k**, **8k**), aldehyde (**7l**, **8l**), ester (**7m**, **8m**), and phthalimide (**7n**, **8n**) groups. In the case of azide **8k**, Sc(OTf)~3~ equilibration in CH~2~Cl~2~ required elevated temperature (60 °C).

In conclusion, we have developed novel, solvent-dependent Sc(OTf)~3~-mediated spirocyclizations of *exo*-glycal epoxides for the stereocontrolled synthesis of benzannulated spiroketals. This *exo*-glycal-based approach overcomes a key limitation of our previous *endo*-glycal-based approach and tolerates a wide range of functionalities. Applications to the diversity-oriented synthesis of stereochemically diverse spiroketal libraries are ongoing and will be reported in due course.

Detailed experimental procedures and analytical data for all new compounds. This material is available free of charge via the Internet at <http://pubs.acs.org>.
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